IDI1 and breast carcinoma: In this sense, it has been demonstrated through microarrays and the RT-qPCR gene expression analysis, that cell treatments with HMGCR inhibitors, differentially induces the expression of HMGCR, HMGCS1 and IDI1 genes in breast cancer cell lines (76).